Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome

被引:3
|
作者
Ali, O. Hasan [1 ,2 ,3 ]
Yurchenko, A. A. [4 ]
Pavlova, O. [5 ]
Sartori, A. [6 ]
Bomze, D. [2 ]
Higgins, R. [1 ]
Ring, S. S. [2 ]
Hartmann, F. [2 ]
Buehler, D. [7 ]
Fritzsche, F. R. [8 ]
Jochum, W. [9 ]
Navarini, A. A. [10 ]
Kim, A. [11 ]
French, L. E. [13 ]
Dermitzakis, E. [6 ]
Christiano, A. M. [11 ,12 ]
Hohl, D. [5 ]
Bickers, D. R. [11 ]
Nikolaev, S., I [4 ,14 ]
Flatz, L. [1 ,2 ,3 ]
机构
[1] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland
[2] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland
[3] Kantonsspital St Gallen, Dept Dermatol Venerol & Allergol, St Gallen, Switzerland
[4] Univ Paris Saclay, Inserm U981, Gustave Roussy Canc Campus, Villejuif, France
[5] CHU Vaudois, Serv Dermatol & Venerol, Lausanne, Switzerland
[6] Univ Geneva, Dept Genet Med & Dev, Med Sch, Geneva, Switzerland
[7] Dermatol Gossau, Gossau, Switzerland
[8] PATHOdiagnost AG, Herisau, Switzerland
[9] Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland
[10] Univ Hosp Basel, Dept Dermatol, Basel, Switzerland
[11] Columbia Univ, Dept Dermatol, Irving Med Ctr, New York, NY 10027 USA
[12] Columbia Univ, Dept Genet & Dev, Irving Med Ctr, New York, NY USA
[13] Ludwig Maximilian Univ Munich, Dept Dermatol & Allergol, Munich, Germany
[14] Univ Paris 07, St Louis Hosp, Paris, France
基金
瑞士国家科学基金会;
关键词
SKIN-CANCER; MUTATIONS;
D O I
10.1111/jdv.16767
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant genetic disorder. It is commonly caused by mutations inPTCH1and chiefly characterized by multiple basal cell carcinomas (BCCs) developing prior to the age of 30 years. In rare cases, NBCCS presents with a late onset of BCC development. Objective To investigate BCC tumorigenesis in two brothers, who showed characteristic features of NBCCS but developed their first BCCs only after the age of 40 years. Two other siblings did not show signs of NBCCS. Results We obtained blood samples from four siblings and nine BCCs from the two brothers with NBCCS. Whole exome sequencing and RNA sequencing revealed loss of heterozygosity (LOH) ofPTCH1in eight out of nine tumours that consistently involved the same haplotype on chromosome 9. This haplotype contained a germinal splice site mutation inPTCH1(NM_001083605:exon9:c.763-6C>A). Analysis of germline DNA confirmed segregation of this mutation with the disease. All BCCs harboured additional somatic loss-of-function (LoF) mutations in the remainingPTCH1allele which are not typically seen in other cases of NBCCS. This suggests a hypomorphic nature of the germinalPTCH1mutation in this family. Furthermore, all BCCs had a similar tumour mutational burden compared to BCCs of unrelated NBCCS patients while harbouring a higher number of damagingPTCH1mutations. Conclusions Our data suggest that a sequence of three genetic hits leads to the late development of BCCs in two brothers with NBCCS: a hypomorphic germline mutation, followed by somatic LOH and additional mutations that completePTCH1inactivation. These genetic events are in line with the late occurrence of the first BCC and with the higher number of damagingPTCH1mutations compared to usual cases of NBCCS.
引用
收藏
页码:396 / 402
页数:7
相关论文
共 50 条
  • [31] Chemoprevention of basal cell carcinoma: reply from authors
    Hoorens, I.
    Brochez, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (06) : 1404 - 1405
  • [32] Two years results of electronic brachytherapy for basal cell carcinoma
    Boilester-Sanchez, Rosa
    Pons-Llanas, Olga
    Candela-Juan, Cristian
    de Unamuno-Bustos, Blanca
    Javier Celada-Alvarez, Francisco
    Tormo-Mico, Alejandro
    Perez-Calatayud, Jose
    Botella-Estrada, Rafael
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2017, 9 (03) : 251 - 255
  • [33] Basal cell nevus syndrome: From DNA to therapeutics
    Lin, Matthew J.
    Dubin, Danielle P.
    Khorasani, Hooman
    Giordano, Cerrene N.
    CLINICS IN DERMATOLOGY, 2020, 38 (04) : 467 - 476
  • [34] Risk factors for early-onset basal cell carcinoma in a German institution
    Bakos, Renato Marchiori
    Kriz, Martin
    Muehlstaedt, Michael
    Kunte, Christian
    Ruzicka, Thomas
    Berking, Carola
    EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (05) : 705 - 709
  • [35] Risk factors for early-onset basal cell carcinomas and the trend towards their female predominance
    Matas-Nadal, Clara
    Sagrista, Marc
    Gomez-Arbones, Xavier
    Sobrino Bermejo, Carmen
    Manel Fernandez-Armenteros, Josep
    Angel Baldo, Joan
    Casanova Seuma, Josep Manel
    Aguayo Ortiz, Rafael
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (03): : 364 - 371
  • [36] Correlation Between the Sites of Onset of Basal Cell Carcinoma and the Embryonic Fusion Planes in the Auricle
    Nicoletti, Giovanni
    Tresoldi, Marco Mario
    Malovini, Alberto
    Prigent, Sebastien
    Agozzino, Manuela
    Faga, Angela
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2018, 12
  • [37] Genital basal cell carcinoma, a different pathogenesis from sun-exposed basal cell carcinoma? A case-control study of 30 cases
    Wang, Yen-Jen
    Tang, Tzu-Yin
    Wang, Jen-Yu
    Huang, Yen-Kai
    Wu, Yu-Hung
    JOURNAL OF CUTANEOUS PATHOLOGY, 2018, 45 (09) : 688 - 695
  • [38] Exceptional Bone Metastasis of Basal Cell Carcinoma in Gorlin-Goltz Syndrome
    Lamon, Tatiana
    Gerard, Stephane
    Meyer, Nicolas
    Losfeld, Benjamin
    van Kan, Gabor Abellan
    Balardy, Laurent
    Vellas, Bruno
    DERMATOLOGY, 2010, 220 (01) : 57 - 59
  • [39] Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome
    Tang, Jean Y.
    Chiou, Albert S.
    Mackay-Wiggan, Julian M.
    Aszterbaum, Michelle
    Chanana, Anita M.
    Lee, Wayne
    Lindgren, Joselyn A.
    Raphael, Maria Acosta
    Thompson, Bobbye J.
    Bickers, David R.
    Epstein, Ervin H., Jr.
    CANCER PREVENTION RESEARCH, 2014, 7 (03) : 292 - 299
  • [40] Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
    Goodman, Aaron M.
    Kato, Shumei
    Cohen, Philip R.
    Boichard, Amelie
    Frampton, Garrett
    Miller, Vincent
    Stephens, Philip J.
    Daniels, Gregory A.
    Kurzrock, Razelle
    ONCOIMMUNOLOGY, 2018, 7 (03):